Filana Therapeutics, Inc. Cash and Restricted Cash
Filana Therapeutics, Inc. (FLNA) had Cash and Restricted Cash of $188.98 million as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2024-11-07
- 2024-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $188.98M.
- 2023-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $142.35M.
- 2023-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $168.44M.
- 2023-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $187.47M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2024-09-30 | $188.98M 10-Q · filed 2024-11-07 |
| 2023-09-30 | $142.35M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $168.44M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $187.47M 10-Q · filed 2023-05-01 |
| 2022-12-31 | $201.01M 10-Q · filed 2023-08-03 |
| 2022-09-30 | $174.66M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $197.23M 10-Q · filed 2023-08-03 |
| 2022-03-31 | $209.69M 10-Q · filed 2023-05-01 |
| 2021-12-31 | $233.44M 10-Q · filed 2023-08-03 |
| 2021-09-30 | $241.52M 10-Q · filed 2022-11-07 |
| 2021-06-30 | $278.25M 10-Q · filed 2022-08-04 |
| 2021-03-31 | $282.19M 10-Q · filed 2022-05-05 |
| 2020-12-31 | $93.51M 10-K · filed 2023-02-28 |
| 2019-12-31 | $23.08M 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |